[Form 4] AUTOLIV INC Insider Trading Activity

Rhea-AI Filing Summary

Autoliv Inc. officer Magnus Jarlegren, President of Autoliv Europe, reported changes in his equity holdings on a Form 4 for transactions dated 12/10/2025. The filing shows multiple entries in the derivative securities table for restricted stock units (RSUs) and performance-based RSUs tied to Autoliv common stock.

The additional RSUs were credited at a price of $0 per unit, reflecting dividend equivalent rights that accrue as extra RSUs when cash dividends are paid on the underlying shares. These new units follow the same vesting schedules as the original grants, including performance-based RSUs tied to three-year performance periods ending December 31, 2025 and December 31, 2026, which vest after the compensation committee certifies performance results.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jarlegren Magnus

(Last) (First) (Middle)

C/O AUTOLIV, INC.

KLARABERGSVIADUKTEN 70, SECTION D5

(Street)

STOCKHOLM V7 SE-111 64

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AUTOLIV INC [ ALV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Autoliv Europe

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance-Based Restricted Stock Units (2023 Grant)	(1)	12/10/2025		A(2)		13.0699		(3)	(3)	Common Stock	13.0699	$0	1,813.857	D
Performance-Based Restricted Stock Units (2024 Grant)	(1)	12/10/2025		A(2)		4.6523		(4)	(4)	Common Stock	4.6523	$0	645.6572	D
Restricted Stock Unit	(1)	12/10/2025		A(2)		4.3516		02/15/2026	02/15/2026	Common Stock	4.3516	$0	603.9274	D
Restricted Stock Unit	(1)	12/10/2025		A(2)		4.2682		02/20/2027	02/20/2027	Common Stock	4.2682	$0	592.3461	D
Restricted Stock Unit	(1)	12/10/2025		A(2)		5.1646		02/20/2028	02/20/2028	Common Stock	5.1646	$0	716.7468	D
Restricted Stock Unit	(1)	12/10/2025		A(2)		54.0929		11/17/2028	11/17/2028	Common Stock	54.0929	$0	7,507.0929	D

Explanation of Responses:

1. Each restricted stock unit (RSU) represents a contingent right to receive one share of ALV common stock.

2. Dividend equivalent rights accrued in the form of additional RSUs. Per the award agreement, cash dividends with a record date on or after the grant date and paid on or before the vesting date yield additional RSUs subject to the same vesting schedule as the underlying RSUs.

3. The performance-based RSUs, as adjusted if necessary, vest and convert to shares in one installment after the completion of the third one-year performance period ending December 31, 2025 and the Leadership Development and Compensation Committee's certification of the level of achievement of the applicable performance objectives.

4. The performance-based RSUs, as adjusted if necessary, vest and convert to shares in one installment after the completion of the third one-year performance period ending December 31, 2026 and the Leadership Development and Compensation Committee's certification of the level of achievement of the applicable performance objectives.

	Brian Kelly by POA from Magnus Jarlegren	12/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Autoliv (ALV) disclose in this Form 4 filing?

The filing reports that officer Magnus Jarlegren, President of Autoliv Europe, received additional restricted stock units and performance-based RSUs in connection with existing equity awards on 12/10/2025.

Why did Magnus Jarlegren receive additional RSUs in Autoliv (ALV)?

He received extra RSUs as dividend equivalent rights, which accrue as additional units when Autoliv pays cash dividends on the underlying shares, in line with the applicable award agreements.

Are the new Autoliv (ALV) RSUs granted to Magnus Jarlegren free of cost?

Yes. The derivative securities table shows the newly credited RSUs and performance-based RSUs with an exercise or conversion price of $0 per unit.

When do the performance-based RSUs reported by Autoliv (ALV) vest?

The performance-based RSUs are scheduled to vest in one installment after the completion of the third one-year performance periods ending on December 31, 2025 and December 31, 2026, following the compensation committee’s certification of performance.

What type of securities are involved in this Autoliv (ALV) Form 4?

The filing involves restricted stock units (RSUs) and performance-based RSUs, each representing a contingent right to receive one share of Autoliv common stock upon vesting.

Does this Autoliv (ALV) Form 4 indicate any stock sales by the officer?

No. The reported transactions reflect RSUs and performance-based RSUs credited at $0 due to dividend equivalents, rather than open market sales of Autoliv shares.